Asia Pacific Custom Antibody Market to Grow at a CAGR of 11.4% to reach US$ 174.8 Mn Million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Custom Antibody Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Custom Antibody Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in biotechnology research and diagnostics
5.1.2 Rising demand for custom antibodies in therapeutic and diagnostic applications

5.2 Market Opportunities

5.2.1 Expansion in antibody therapies and diagnostics
5.2.2 Rising opportunities for companies to invest in custom antibody development

5.3 Future Trends

5.3.1 Use of monoclonal antibodies in personalized medicine
5.3.2 Increasing trends in custom antibody development for targeted therapeutics

5.4 Impact of Drivers and Restraints

6. Asia Pacific Custom Antibody Market Regional Analysis

6.1 Asia Pacific Custom Antibody Market Overview

6.2 Asia Pacific Custom Antibody Market Revenue 2019-2028 (US$ Million)

6.3 Asia Pacific Custom Antibody Market Forecast Analysis

7. Asia Pacific Custom Antibody Market Analysis – by Service

7.1 Antibody Development

7.1.1 Overview
7.1.2 Antibody Development: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Antibody Production and Purification

7.2.1 Overview
7.2.2 Antibody Production and Purification: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Antibody Fragmentation and Labelling

7.3.1 Overview
7.3.2 Antibody Fragmentation and Labelling: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Custom Antibody Market Analysis – by Type

8.1 Monoclonal Antibodies

8.1.1 Overview
8.1.2 Monoclonal Antibodies: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Polyclonal Antibodies

8.2.1 Overview
8.2.2 Polyclonal Antibodies: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Other Custom Antibodies

8.3.1 Overview
8.3.2 Other Custom Antibodies: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Custom Antibody Market Analysis – by Source

9.1 Mice

9.1.1 Overview
9.1.2 Other Custom Antibodies: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Rabbits

9.2.1 Overview
9.2.2 Other Custom Antibodies: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Custom Antibody Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Custom Antibody Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Asia Pacific Custom Antibody Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 China: Asia Pacific Custom Antibody Market Breakdown, by Service
10.1.1.1.2 China: Asia Pacific Custom Antibody Market Breakdown, by Type
10.1.1.1.3 China: Asia Pacific Custom Antibody Market Breakdown, by Source

10.1.1.2 India: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 India: Asia Pacific Custom Antibody Market Breakdown, by Service
10.1.1.2.2 India: Asia Pacific Custom Antibody Market Breakdown, by Type
10.1.1.2.3 India: Asia Pacific Custom Antibody Market Breakdown, by Source

10.1.1.3 Japan: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Custom Antibody Market Breakdown, by Service
10.1.1.3.2 Japan: Asia Pacific Custom Antibody Market Breakdown, by Type
10.1.1.3.3 Japan: Asia Pacific Custom Antibody Market Breakdown, by Source

10.1.1.4 Australia: Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Custom Antibody Market Breakdown, by Service
10.1.1.4.2 Australia: Asia Pacific Custom Antibody Market Breakdown, by Type
10.1.1.4.3 Australia: Asia Pacific Custom Antibody Market Breakdown, by Source

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Custom Antibody Market Breakdown, by Service
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Custom Antibody Market Breakdown, by Type
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Custom Antibody Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Custom Antibody Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bio-Rad Laboratories Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Merck KGAA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Abcam

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Genscript

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Agilent Technologies, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Cell Signaling Technology, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights